Azenta, Inc.

Listed Company

AZTACIK 0000933974NasdaqLarge AcceleratedSpecial Industry Machinery, NecDelawareFY ends Sep 30

Period

FY 2025

Revenue

$593.82M

Net Income

$-55.76M

Total Assets

$2.06B

Equity

$1.73B

Shares Out

46.06M

Op. Cash Flow

$72.18M

Business

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry, focusing on automated ultra‑cold storage and genomic services. It offers automated storage systems, cryogenic freezers, automated sample tubes, consumables and instruments, controlled rate thawing devices, sample repository services, and genomic services including gene sequencing and synthesis. The company operates through two reportable segments: Sample Management Solutions and Multiomics. It serves pharmaceutical, biotechnology, academic, government and research customers globally via direct sales, distributors and local service centers.

Summary from filing dated 2025-12-04

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-09-30	FY 2024 2024-09-30	FY 2023 2023-09-30	FY 2022 2022-09-30	FY 2021 2021-09-30
Total revenue	594	573	551	555	514
Total cost of revenue	324	319	312	300	270
Gross profit	270	255	239	256	244
Research and development	30	32	32	28	22
Selling, general and administrative	262	263	264	251	252
Impairment of goodwill and intangible assets	0	5	0	—	—
Restructuring charges	5	7	5	712,000	385,000
Total operating expenses	297	306	300	280	275
Operating loss	−27	−51	−61	−25	−31
Interest income, net	19	33	44	—	—
Other income (expense), net	922,000	−732,000	−2	−898,000	−16
Loss from continuing operations before income taxes	−7	−19	−20	−10	−49
Income tax (benefit) expense	−32	5	−12	1	−20
Income (loss) from continuing operations	24	−24	−8	−11	—
Loss from discontinued operations, net of tax	−80	−141	−7	2,144	140
Net loss	−56	−165	−15	2,133	111
Income (loss) from continuing operations (in dollars per share)	0.53	−0.46	−0.12	−0.15	−0.39
Loss from discontinued operations, net of tax (in dollars per share)	−1.75	−2.64	−0.1	28.63	1.88
Net loss per share (in dollars per share)	−1.22	−3.1	−0.22	28.48	1.49
Income (loss) from continuing operations (in dollars per share)	0.53	−0.46	−0.12	−0.15	−0.39
Loss from discontinued operations, net of tax (in dollars per share)	−1.75	−2.64	−0.1	28.63	1.88
Diluted net loss per share (in dollars per share)	−1.22	−3.1	−0.22	28.48	1.49
Basic (in shares)	46	53	66	75	74
Diluted (in shares)	46	53	66	75	74

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-09-30	FY 2025 2025-06-30	FY 2025 2025-03-31	FY 2024 2024-12-31	FY 2024 2024-09-30
Cash and cash equivalents	280	—	—	—	280
Short-term marketable securities	61	—	—	—	151
Accounts receivable, net of allowance for expected credit losses ($4,649 and $5,349, respectively)	142	—	147	152	154
Inventories	75	81	75	75	71
Short-term restricted cash	2	—	—	—	2
Refundable income taxes	10	—	—	—	24
Prepaid expenses and other current assets	65	75	67	72	51
Current assets held for sale	74	—	91	83	99
Total current assets	708	678	710	848	833
Property, plant and equipment, net	154	—	—	—	156
Long-term marketable securities	202	—	—	—	49
Long-term deferred tax assets	726,000	—	—	—	837,000
Operating lease right-of-use assets	54	—	—	—	60
Goodwill	702	—	—	—	691
Intangibles assets, net	102	—	—	—	125
Long term income taxes receivable	46	—	—	—	0
Other assets	6	—	7	—	11
Noncurrent assets held for sale	85	—	133	—	174
Total assets	2,060	2,019	2,034	2,043	2,100
Accounts payable	38	38	39	—	33
Deferred revenue	32	—	—	—	30
Derivative liability	33	—	—	—	2
Accrued warranty and retrofit costs	5	—	—	—	5
Accrued compensation and benefits	36	32	26	29	29
Accrued customer deposits	26	—	—	—	22
Accrued income taxes payable	9	9	10	7	9
Accrued expenses and other current liabilities	30	—	—	—	44
Current liabilities held for sale	28	—	—	—	30
Total current liabilities	238	246	221	203	206
Long-term deferred tax liabilities	18	20	22	19	18
Long-term operating lease liabilities	51	—	—	—	57
Other long-term liabilities	11	—	—	—	9
Noncurrent liabilities held for sale	14	—	31	—	42
Total liabilities	333	346	339	323	332
Preferred stock, $0.01 par value - 1,000,000 shares authorized, no shares issued or outstanding	0	—	—	—	0
Common stock, $0.01 par value - 125,000,000 shares authorized, 59,320,848 shares issued and 45,858,979 shares outstanding at September 30, 2025, 59,031,953 shares issued and 45,570,084 shares outstanding at September 30, 2024	594,000	—	—	—	590,000
Additional paid-in capital	530	524	—	—	506
Accumulated other comprehensive loss	−22	−20	−42	−55	−13
Treasury stock, at cost - 13,461,869 shares at September 30, 2025 and September 30, 2024	−201	—	—	—	−201
Retained earnings	1,420	1,369	1,417	1,465	1,476
Total stockholders' equity	1,727	1,673	1,695	1,720	1,768
Total liabilities and stockholders' equity	2,060	2,019	2,034	2,043	2,100

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-09-30	FY 2024 2024-09-30	FY 2023 2023-09-30	FY 2022 2022-09-30	FY 2021 2021-09-30
Depreciation and amortization	61	91	86	54	65
Impairment of goodwill and intangible assets	0	116	0	—	—
Loss on assets held for sale	93	0	0	—	—
Property, plant and equipment and other asset write-offs	3	4	0	—	—
Inventory write-downs	0	3	0	—	—
Other non-cash charges related to restructuring and transformation	0	4	0	0	—
Stock-based compensation	21	14	9	11	27
Contingent consideration adjustment	0	0	−19	—	—
Amortization and accretion on marketable securities	−2	−6	−8	−2	225,000
Deferred income taxes	−27	−16	−29	24	−17
Purchase accounting impact on inventory	0	0	10	0	—
Loss on disposals of property, plant and equipment	711,000	296,000	43,000	−21,000	260,000
Accounts receivable	21	−12	34	−31	−70
Inventories	−3	16	8	−67	−50
Accounts payable	1	9	−15	−4	31
Deferred revenue	641,000	−4	−8	17	−4
Accrued warranty and retrofit costs	−435,000	−684,000	5	303,000	—
Accrued compensation and tax withholdings	7	−3	−19	11	—
Long term income taxes receivable	−46	0	0	—	—
Other assets and liabilities	−4	−3	−35	913,000	—
Net cash provided by operating activities	72	50	6	−466	150
Purchases of property, plant and equipment	−34	−37	−39	−73	−53
Purchases of marketable securities and other investments	−451	−406	−236	−1,976	−151,000
Sales and maturities of marketable securities	390	666	1,064	705	121,000
Proceeds from other investment	2	0	0	—	—
Net investment hedge settlement	3	1	29	0	—
Acquisitions, net of cash acquired	0	0	−387	−126	−94
Net cash (used in) provided by investing activities	−90	225	431	1,466	−146
Proceeds from issuance of common stock	3	3	4	5	6
Payments of finance leases	−985,000	−783,000	−578,000	−388,000	—
Withholding tax payments on net share settlements on equity awards	0	0	−5	0	—
Share repurchases	0	−662	−839	0	—
Excise tax payment for settled share repurchases	−11	0	0	—	—
Net cash used in financing activities	−10	−659	−840	−63	−26
Effects of exchange rate changes on cash, cash equivalents and restricted cash	4	22	46	−181	5
Net decrease in cash, cash equivalents and restricted cash	−24	−363	−357	756	−17
Cash paid for income taxes, net	7	3	43	452	38
Purchases of property, plant and equipment included in accounts payable and accrued expenses	6	3	3	10	—

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro